GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Clariane SE (XPAR:CLARI) » Definitions » EV-to-EBITDA

Clariane SE (XPAR:CLARI) EV-to-EBITDA : 8.59 (As of Jun. 14, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Clariane SE EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Clariane SE's enterprise value is €8,300 Mil. Clariane SE's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €966 Mil. Therefore, Clariane SE's EV-to-EBITDA for today is 8.59.

The historical rank and industry rank for Clariane SE's EV-to-EBITDA or its related term are showing as below:

XPAR:CLARI' s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.59   Med: 11.44   Max: 14.62
Current: 8.59

During the past 13 years, the highest EV-to-EBITDA of Clariane SE was 14.62. The lowest was 8.59. And the median was 11.44.

XPAR:CLARI's EV-to-EBITDA is ranked better than
69.83% of 464 companies
in the Healthcare Providers & Services industry
Industry Median: 12.49 vs XPAR:CLARI: 8.59

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-14), Clariane SE's stock price is €1.8572. Clariane SE's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.989. Therefore, Clariane SE's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Clariane SE EV-to-EBITDA Historical Data

The historical data trend for Clariane SE's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clariane SE EV-to-EBITDA Chart

Clariane SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.34 12.33 10.87 9.83 8.89

Clariane SE Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.87 - 9.83 - 8.89

Competitive Comparison of Clariane SE's EV-to-EBITDA

For the Medical Care Facilities subindustry, Clariane SE's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clariane SE's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Clariane SE's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Clariane SE's EV-to-EBITDA falls into.



Clariane SE EV-to-EBITDA Calculation

Clariane SE's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=8300.261/965.804
=8.59

Clariane SE's current Enterprise Value is €8,300 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Clariane SE's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €966 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clariane SE  (XPAR:CLARI) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Clariane SE's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.8572/-0.989
=At Loss

Clariane SE's share price for today is €1.8572.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Clariane SE's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.989.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Clariane SE EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Clariane SE's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Clariane SE (XPAR:CLARI) Business Description

Traded in Other Exchanges
Address
21-25, Rue Balzac, Paris, FRA, 75008
Clariane SE operates nursing homes, post-acute and rehabilitation clinics, assisted living facilities, and home care services. Its operating segments are France, Germany, Italy, and Belgium. The majority of its revenue is generated in France. Its nursing homes offer long-term care and medical support for elderly people.

Clariane SE (XPAR:CLARI) Headlines

No Headlines